Jess S. Morgan & Co’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.37M | Buy |
366,401
+51,100
| +16% | +$331K | 2.07% | 25 |
|
|
2022
Q2 | $1.44M | Buy |
315,301
+24,800
| +9% | +$114K | 1.5% | 25 |
|
|
2022
Q1 | $2.51M | Buy |
290,501
+75,100
| +35% | +$650K | 1.83% | 30 |
|
|
2021
Q4 | $3.08M | Buy |
215,401
+1,500
| +0.7% | +$21.4K | 1.89% | 31 |
|
|
2021
Q3 | $4.7M | Sell |
213,901
-108,348
| -34% | -$2.38M | 3.1% | 6 |
|
|
2021
Q2 | $4.31M | Sell |
322,249
-57,695
| -15% | -$772K | 2.83% | 16 |
|
|
2021
Q1 | $3.86M | Sell |
379,944
-197,373
| -34% | -$2.01M | 2.7% | 14 |
|
|
2020
Q4 | $2.45M | Buy |
577,317
+1,000
| +0.2% | +$4.24K | 1.95% | 31 |
|
|
2020
Q3 | $1.5M | Buy |
576,317
+163,424
| +40% | +$426K | 1.5% | 35 |
|
|
2020
Q2 | $1.46M | Buy |
412,893
+380,993
| +1,194% | +$1.35M | 1.58% | 34 |
|
|
2020
Q1 | $97K | Buy |
31,900
+1,000
| +3% | +$3.04K | 0.13% | 35 |
|
|
2019
Q4 | $159K | Buy |
+30,900
| New | +$159K | 0.16% | 39 |
|